Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yi‐Lin Chen
Observed name:
Yi-Lin Chen
Institutions:
National Cheng Kung University Hospital,
National Cheng Kung University
Observed institutions:
National Cheng Kung University Hospital,
National Cheng Kung University
ORCID:
0000-0001-9323-062X
Observed ORCID:
0000-0001-9323-062X
OpenAlex ID:
A5028458872
Effectiveness of Individual-Based Strategies to Reduce Nurse Burnout: An Umbrella Review
2024
·
Hsiang-Chin Hsu
, Huan-Fang Lee
, et al.
·
Journal of Nursing Management
·
51
PDF
Costs of biomarker testing in advanced non‐small cell lung cancer: a global study comparing next‐generation sequencing and single‐gene testing
2025
·
Umberto Malapelle
, Chien‐Chin Chen
, et al.
·
The Journal of Pathology Clinical Research
·
12
Genomic instabilities in hepatocellular carcinoma: biomarkers and application in immunotherapies
2024
·
Jui-Hsiang Hung
, Chiao-Feng Teng
, et al.
·
Annals of Hepatology
·
11
High concordance rate of capillary electrophoresis workflow for microsatellite instability analysis and mismatch repair (MMR) immunostaining in colorectal carcinoma
2023
·
Wenya Huang
, Chung-Liang Ho
, et al.
·
PLoS ONE
·
3
PDF
Potential of epithelial membrane protein 3 as a novel therapeutic target for human breast cancer
2024
·
Yi-Wen Wang
, Yih-Lin Tuan
, et al.
·
Oncology Reports
·
2
PDF
Clinical implications of PNA‑sequencing as a complementary test for EGFR mutation analysis in human lung cancer
2023
·
Yi-Lin Chen
, Chien-Chung Lin
, et al.
·
Oncology Letters
·
2
PDF
A digital polymerase chain reaction method targeting non-recombined T-cell receptor sequences aids in diagnosing primary cutaneous T-cell lymphomas
2026
·
Chien-Chin Chen
, Cheng-Lin Wu
, et al.
·
Journal of Cancer
PDF
Acquired ROS1 Intragenic Rearrangements as a Resistance Mechanism in EGFR-Mutant Non-Small Cell Lung Cancer: A Case Series
2026
·
Po-Tsen Liu
, Yi-Lin Chen
, et al.
·
Current Oncology
Correction: Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung Adenocarcinoma
2025
·
Huang-Tz Ou
, Jui-Hung Tsai
, et al.
·
PharmacoEconomics
PDF
Show more works
View as search
Works count:
9
Citation count:
81
H-index:
3
I10-index:
3
Year
Topic
Type